Ownes & Minor (OMI) Declares $0.2575 Quarterly Dividend; 4.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Ownes & Minor (OMI) Misses Q3 EPS by 10c; Lowers Outlook
November 1, 2017 7:05 AM EDTOwnes & Minor (NYSE: OMI) reported Q3 EPS of $0.40, $0.10 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.4 billion.
GUIDANCE:
Ownes & Minor sees FY2017 EPS of $1.75-$1.85, versus the consensus of... More
Halyard Health (HYH) to Sell S&IP Business to Owens & Minor (OMI) for $710M
November 1, 2017 7:03 AM EDTHalyard Health, Inc. (NYSE: HYH) today announced it has entered into a definitive agreement with Owens & Minor, Inc. (NYSE: OMI) to sell its Surgical and Infection Prevention ("S&IP") business for $710 million. S&IP provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
The divestiture of the S&IP business accelerates Halyard's transformation into a pure-play medical devices business, with market leading positions in its core franchises of pain management and chronic care. As a growth-oriented business with a singular focus... More
